Key result
Parathyroidectomy reduced left ventricular mass in patients with primary hyperparathyroidism, with greater improvements in shorter-term studies.
Why the study?
Does parathyroidectomy reduce left ventricular mass in patients with primary hyperparathyroidism?
Meta-Analysis (n=457)
Does parathyroidectomy reduce left ventricular mass in patients with primary hyperparathyroidism?
Parathyroidectomy reduces left ventricular mass in patients with primary hyperparathyroidism, particularly in the short term and in those with higher preoperative PTH levels.
Answers are grounded in this paper and cite their sources.
Supports parathyroidectomy for LV mass reduction in primary hyperparathyroidism; confirms benefit via meta-analysis.
CONTEXT: Primary hyperparathyroidism (PHPT) has been associated with increased left ventricular mass (LVM) in many studies. Most studies have been inadequately powered to assess the effect of parathyroidectomy (PTX) on LVM. OBJECTIVE: The objective was to evaluate whether PTX has a benefit on LVM in patients with PHPT. DATA SOURCES: Sources included PubMed, Medline, Cochrane Library, clinicaltrials.gov, review articles, and abstracts from meetings. STUDY SELECTION: Eligible studies included prospective studies of PTX vs observation or PTX alone in patients with PHPT who had LVM measured by echocardiography. DATA EXTRACTION: Two investigators independently identified eligible studies and extracted data. Random-effects models were used to obtain final pooled estimates. DATA SYNTHESIS: Fifteen studies (four randomized controlled trials and 11 observational) of 457 participants undergoing PTX were included. PTX was associated with a reduction in LVM (crude Hedges gu -0.290 ± 0.070, 95% confidence interval [CI] -0.423 to -0.157) of 11.6 g/m(2) (12.5%) on average. Effect size estimates differed by study duration (P < .001), with improvements seen in shorter (≤ 6 mo) but not longer studies. There was a trend toward greater improvement in observational studies vs randomized controlled trials (P = .07), and both serum calcium and PTH were higher in the former. Using random-effects models, the estimated effect size remained significant (Hedges gu -0.250, 95% CI -0.450 to -0.050). Higher preoperative PTH but not calcium was associated with a greater decline in LVM (β = -.039, 95% CI -0.075 to -0.004). CONCLUSION: PTX reduced LVM in PHPT, and higher preoperative PTH levels were associated with greater improvements. Because the benefit was limited to short-term studies and PHPT disease severity was not independent of study design, further work is needed to clarify the factors that influence the change in LVM and whether the benefit persists beyond 6 months after PTX. Although the clinical significance of the LVM improvement is unclear, these data indicate that PTH may underlie increased LVM in PHPT.
No takes yet. Share an insight, caveat, or question.
McMahon et al. (2015) conducted a meta-analysis in Primary hyperparathyroidism (PHPT) (n=457). Parathyroidectomy (PTX) vs. Observation or baseline was evaluated on Left ventricular mass (LVM) (Hedges g -0.250, 95% CI -0.450 to -0.050). Parathyroidectomy reduced left ventricular mass in patients with primary hyperparathyroidism, with greater improvements in shorter-term studies.
Synapse has enriched 10 related papers. Consider them for comparative context: